CARDIOVASCULAR EFFECTS OF ANOXIA AND THE INFLUENCE OF A NEW BETA ADRENERGIC RECEPTOR BLOCKING DRUG.
D000319:Adrenergic beta-Antagonists; D000818:Animals; D001794:Blood Pressure; D001808:Blood Vessels; D002319:Cardiovascular System; D003331:Coronary Vessels; D004285:Dogs; D004837:Epinephrine; D006321:Heart; D000860:Hypoxia; D007545:Isoproterenol; D009638:Norepinephrine; D010600:Pharmacology; D011652:Pulmonary Circulation; D011943:Receptors, Adrenergic, beta; D012106:Research; D013565:Sympatholytics
D000319:Adrenergic beta-Antagonists; D011943:Receptors, Adrenergic, beta; D013565:Sympatholytics; D007545:Isoproterenol; D009638:Norepinephrine; D004837:Epinephrine
ANOXIA; BLOOD PRESSURE; BLOOD VESSELS; CORONARY VESSELS; DOGS; EPINEPHRINE; EXPERIMENTAL LAB STUDY; HEART; ISOPROTERENOL; NOREPINEPHRINE; PHARMACOLOGY; PULMONARY CIRCULATION; SYMPATHOLYTICS